Vimarsana
Biggest News Aggregation in the World

Page 48 - E Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from E Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In E Ltd Today - Breaking & Trending Today

Bio E vaccine candidate gets Ph-III trial nod | India News - Vimarsana News

Bio E vaccine candidate gets Ph-III trial nod | India News

HYDERABAD: Vaccine maker Biological E Ltd has received approval from the subject expert committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to start phase III clinical trials of its Covid-19 subunit vaccine candidate, reports Swati Bharadwaj. The company is developing the vaccine with Texas-based Baylor College of Medicine (BCM). The phase III trials of the recombinant protein vaccine will be conducted on 1,268 healthy volunteers in the 18 to 80 age bracket across 15 sites in India to evaluate the immunogenicity and safety of the vaccine. This is part of a larger globa...

U.S. to provide vaccine components, medical supplies as India battles COVID-19 spike - Vimarsana News

U.S. to provide vaccine components, medical supplies as India battles COVID-19 spike

Article content WILMINGTON — The United States will immediately send raw materials for COVID-19 vaccines, medical equipment and protective gear to help India respond to a massive surge in coronavirus infections, U.S. President Joe Biden said on Sunday. “Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, we are determined to help India in its time of need,” Biden said on Twitter after the White House announced a list of measures. We apologize, but this video has failed to load. Try refreshing your browser, or U.S. to provide vaccine ...

Bio E vax candidate gets SEC nod for phase III trials | Hyderabad News - Vimarsana News

Bio E vax candidate gets SEC nod for phase III trials | Hyderabad News

Image used for representational purpose only HYDERABAD: Vaccine maker Biological E Ltd has received approval from the subject expert committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to start phase III clinical trials of its Covid-19 subunit vaccine candidate. The company is developing the vaccine with Texas-based Baylor College of Medicine (BCM). The phase III trials of the recombinant protein vaccine will be conducted on 1,268 healthy volunteers in the 18 to 80 age bracket across 15 sites in India to evaluate the immunogenicity and safety of the vaccine. This is pa...

U.S. Says It'll Send India Vaccine Materials, Boost Aid Finance - Vimarsana News

U.S. Says It'll Send India Vaccine Materials, Boost Aid Finance

U.S. Says It’ll Send India Vaccine Materials, Boost Aid Finance Bloomberg 3 hrs ago Tony Czuczka (Bloomberg) -- The U.S. will send India raw materials for vaccines and step up financing aid for Covid-19 shot production, joining European countries in pledging to help stem the world’s biggest surge in cases. “Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, we are determined to help India in its time of need,” President Joe Biden tweeted on Sunday. Material needed to produce Covishield, the Oxford-AstraZeneca vacc...

Source: msn.com
US to provide urgently needed vaccine components, medical supplies to India - Vimarsana News

US to provide urgently needed vaccine components, medical supplies to India

US to provide urgently needed vaccine components, medical supplies to India A doctor tends to a patient with a breathing problem inside an ambulance waiting to enter a COVID-19 hospital for treatment, amidst the spread of the coronavirus disease (COVID-19) in Ahmedabad, India, April 25, 2021. Photo: Reuters/Amit Dave Reuters, Wilmington Reuters, Wilmington The United States will immediately provide raw materials for Covid-19 vaccines, medical equipment and protective gear to help India respond to a massive surge in Covid-19 infections, a White House spokeswoman said on Sunday. "The United S...